CXCL13型
B细胞激活因子
高内皮静脉
趋化因子
医学
C-C趋化因子受体7型
免疫学
淋巴系统
CCL21型
免疫系统
CCL7型
滤泡树突状细胞
病理
生物
B细胞
趋化因子受体
T细胞
抗体
抗原提呈细胞
作者
Francesco Ciccia,Aroldo Rizzo,Rosario Maugeri,Riccardo Alessandro,Stefania Croci,Giuliana Guggino,Alberto Cavazza,Stefania Raimondo,Alessandra Cannizzaro,Domenico Gerardo Iacopino,Carlo Salvarani,G Triolo
标识
DOI:10.1136/annrheumdis-2016-209217
摘要
Objectives To investigate whether artery tertiary lymphoid organs (ATLOs) are present in giant cell arteritis (GCA) and that their formation is associated with the ectopic expression of constitutive lymphoid tissue-homing chemokines. Methods Reverse transcriptase PCR, immunohistochemical and immunofluorescence analysis were used to determine the presence of ectopic ATLOs in GCA and the expression of chemokines/chemokine receptors and cytokines involved in lymphoneogenesis in the temporal artery samples obtained from 50 patients with GCA and 30 controls. The presence of lymphatic conduits, of follicular dendritic cells (FDCs) precursors and lymphoid tissue inducer cells was also investigated. Finally, expression of CXCL13, B cell activating factor (BAFF), a proliferation-inducing ligand (APRIL) and CCL21 by isolated myofibroblasts was evaluated before and after stimulation with Toll-like receptors (TLRs) agonists and cytokines. Results ATLOs were observed in the media layer of 60% of patients with GCA in close proximity to high endothelial venules and independently by the age of patients and the presence of atherosclerosis. ATLO formation was also accompanied by the expression of CXCL13, BAFF, a proliferation-inducing ligand (APRIL), lymphotoxin (LT)-β, interleukin (IL)-17 and IL-7, the presence of FDC precursors and of lymphoid conduits. Stimulation of myofibroblasts with TLR agonists and cytokines resulted in the upregulation of BAFF and CXCL13. Conclusions ATLOs occur in the inflamed arteries of patients with GCA possibly representing the immune sites where immune responses towards unknown arterial wall-derived antigens may be organised.
科研通智能强力驱动
Strongly Powered by AbleSci AI